Intrinsiqs

Is Ironwood Pharmaceuticals, Inc. overvalued?

Ironwood Pharmaceuticals, Inc. (IRWD) looks undervalued — trading about 116% below its fair value.

Undervalued
Current price $4.83 Fair value $10.43
Price
$4.83
Fair value
$10.43
Current P/E
7.9
Normal P/E
17.1
Market cap
$799.6M
Dividend yield
0.0%
Return on equity
-93.4%
Sector
Healthcare

See the full interactive analysis →

Fair value compares IRWD's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.

Related stocks

LLY Eli Lilly and CompanyJNJ Johnson & JohnsonABBV AbbVie Inc.RHHBY Roche Holding AGUNH UnitedHealth Group IncorporatedMRK Merck & Co., Inc.